Hot Pursuit     15-Mar-25
Zydus Life’s Gujarat facility clears USFDA inspection with zero observations
Zydus Lifesciences has announced that the US Food and Drug Administration (USFDA) conducted a surveillance inspection at the company’s Active Pharmaceutical Ingredient (API) Unit 1, located in Ankleshwar, Gujarat.

The said inspection was conducted from 10 March to 14 March 2025 and concluded with zero observations from the regulatory body.

The official announcement was made on 14 March 2025.

Zydus Lifesciences is a discovery-driven, global life sciences company that discovers, develops, manufactures, and markets a broad range of healthcare therapies.

The company reported a 29.62% jump in consolidated net profit of Rs 1,023.5 crore in Q3 FY25 compared with Rs 789.6 crore in Q3 FY24. Revenue from operations increased 16.96% YoY to Rs 5,269.1 crore during the quarter.

Shares of Zydus Lifesciences fell 0.73% to end at Rs 882.55 on Thursday, 13 March 2025.

Previous News
  Zydus Life Matoda facility receives two observations from USFDA after inspection
 ( Hot Pursuit - 19-Jun-25   09:50 )
  Zydus Life subsidiary ZHL appoints Swati Dalal as MD
 ( Hot Pursuit - 16-Jun-25   14:42 )
  Zydus Lifesciences appoints Managing Director
 ( Corporate News - 16-Jun-25   14:16 )
  Zydus' Ankleshwar API unit clears USFDA inspection
 ( Corporate News - 12-Jun-25   10:41 )
  Zydus Life receives USFDA EIR for Gujarat facility
 ( Hot Pursuit - 12-Jun-25   09:55 )
  Zydus Life receives USFDA EIR for Dabhasa API facility
 ( Hot Pursuit - 10-Jun-25   15:19 )
  Zydus receives EIR for the API manufacturing facility at Dabhasa
 ( Corporate News - 10-Jun-25   14:11 )
  Zydus Lifesciences Ltd spurts 0.24%, up for fifth straight session
 ( Hot Pursuit - 10-Jun-25   13:00 )
  Stock Alert: Yes Bank, Zydus Lifesciences, Ashok Leyland, R Systems Intl
 ( Market Commentary - Stock Alert 04-Jun-25   08:05 )
  Zydus Lifesciences gets USFDA nod for Rifaximin tablets
 ( Hot Pursuit - 02-Jun-25   10:47 )
  Zydus Lifesciences receives USFDA tentative approval for Rifaximin Tablets
 ( Corporate News - 02-Jun-25   09:12 )
Other Stories
  Rajshree Polypack bags Rs 3-cr supply order
  05-Jul-25   16:04
  Power and Instrumentation secures Rs 3-cr work order from Nyati Engineering & Construction
  05-Jul-25   15:06
  RVNL bags Rs 143 cr LoA from Southern Railway for traction system upgrade in Tamil Nadu
  05-Jul-25   13:27
  Dhanlaxmi Bank gross advances rises 17% YoY in Q1 FY26
  05-Jul-25   12:45
  Texmaco Rail secures Rs 36-cr wagon order from TCI
  05-Jul-25   12:12
  Hazoor Multi Projects bags Rs 913-cr solar order from Apollo Green Energy
  05-Jul-25   11:27
  BEML secures $6.23 million export orders
  05-Jul-25   11:04
  Shakti Pumps raises Rs 292.6 crore via QIP; PineBridge, LIC MF among top investors
  05-Jul-25   09:52
  Bank of Maharashtra’s total deposits climb 14% YoY to Rs 3.05 lakh crore in Q1
  04-Jul-25   17:35
  GPT Infraprojects bags supply contract from Bangladesh-based Standard Engineers
  04-Jul-25   16:01
Back Top